Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysis

Hyperleukocytosis is associated with a significant early mortality rate in patients with acute myeloid leukemia (AML). To date, no controlled trial has ever evaluated a strategy to reduce this risk, and the initial management of these patients remains heterogeneous worldwide. The aim of the present...

Descripción completa

Detalles Bibliográficos
Autores principales: Cerrano, Marco, Chevret, Sylvie, Raffoux, Emmanuel, Rabian, Florence, Sébert, Marie, Valade, Sandrine, Itzykson, Raphael, Lemiale, Virginie, Adès, Lionel, Boissel, Nicolas, Dombret, Hervé, Azoulay, Elie, Lengliné, Etienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919741/
https://www.ncbi.nlm.nih.gov/pubmed/36773040
http://dx.doi.org/10.1007/s00277-023-05119-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919741/
https://www.ncbi.nlm.nih.gov/pubmed/36773040
http://dx.doi.org/10.1007/s00277-023-05119-3

Ejemplares similares